Lee Schwamm

Lee Schwamm

Harvard University

H-index: 124

North America-United States

About Lee Schwamm

Lee Schwamm, With an exceptional h-index of 124 and a recent h-index of 77 (since 2020), a distinguished researcher at Harvard University, specializes in the field of cerebrovascular disease, innovation, telehealth.

His recent articles reflect a diverse array of research interests and contributions to the field:

Evaluating the Concordance Between International Classification of Diseases, Tenth Revision Code, and Stroke Severity as Measured by the National Institutes of Health Stroke …

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial

Benzodiazepine Initiation and the Elevated Risk of Falls and Fall-related Injuries in Older Adults Following Acute Ischemic Stroke (P2-5.008)

Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial

Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)

Winning the Battle of Timely Guideline-Directed Medical Therapy Titration

Critical Domains Within the Self-Reported Patient Experience of Virtual Care

Evaluating the Concordance between ICD-10 and Stroke Severity as Measured by the NIHSS

Lee Schwamm Information

University

Position

Professor of Neurology, Harvard Medical School

Citations(all)

143582

Citations(since 2020)

55405

Cited By

108637

hIndex(all)

124

hIndex(since 2020)

77

i10Index(all)

468

i10Index(since 2020)

386

Email

University Profile Page

Google Scholar

Lee Schwamm Skills & Research Interests

cerebrovascular disease

innovation

telehealth

Top articles of Lee Schwamm

Evaluating the Concordance Between International Classification of Diseases, Tenth Revision Code, and Stroke Severity as Measured by the National Institutes of Health Stroke …

2024/4/14

Mohamed Taha
Mohamed Taha

H-Index: 5

Lee Schwamm
Lee Schwamm

H-Index: 74

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial

Stroke and Vascular Neurology

2024/2/1

Benzodiazepine Initiation and the Elevated Risk of Falls and Fall-related Injuries in Older Adults Following Acute Ischemic Stroke (P2-5.008)

2024/4/14

Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial

Stroke and Vascular Neurology

2024/1/31

Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)

2024/4/14

Lee Schwamm
Lee Schwamm

H-Index: 74

John Hsu
John Hsu

H-Index: 30

Winning the Battle of Timely Guideline-Directed Medical Therapy Titration

2024/4/1

Critical Domains Within the Self-Reported Patient Experience of Virtual Care

JAMA Network Open

2024/1/2

Evaluating the Concordance between ICD-10 and Stroke Severity as Measured by the NIHSS

medRxiv

2024

Association of Traditional and Nontraditional Risk Factors in the Development of Strokes Among Young Adults by Sex and Age Group: A Retrospective Case-Control Study

Circulation: Cardiovascular Quality and Outcomes

2024/4

Benzodiazepine Initiation and the Risk of Falls or Fall-Related Injuries in Older Adults Following Acute Ischemic Stroke

medRxiv

2024

Digital Health for Oncological Care

2024/1/1

Thrombolysis for Wake-Up Stroke Versus Non–Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis

Stroke

2024/4

Higher Procedural Volumes are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute …

Annals of Neurology

2024/1

Global stroke statistics 2023: Availability of reperfusion services around the world

2024/3

Reimagining Stroke Quality of Care in the Age of Artificial Intelligence and Digital Enablement

Stroke

2024/2/21

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

JAMA neurology

2024/2/9

Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection

New England Journal of Medicine

2024/2/8

COVID‐19 Infection Is Associated With Poor Outcomes in Patients With Intracerebral Hemorrhage

Journal of the American Heart Association

2024/2/6

Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021

JAMA Network Open

2024/2/5

Contemporarypre-Stroke Antiplatelet Use and the Risk of Symptomatic Hemorrhagic Transformation After Intravenous Thrombolysis

Stroke

2024/2

See List of Professors in Lee Schwamm University(Harvard University)